Opioid Abuse-Deterrent Labeling Claim Decision By FDA Could Come Soon

Drug sponsors could soon learn what data FDA considers sufficient to support a labeling claim of abuse-deterrence for an opioid drug.

The agency has received inquiries about specific products and “whether the agency believes that those products are, in fact, abuse-deterrent,”...